Cargando…
PRIMED(2) Preclinical Evidence Scoring Tool to Assess Readiness for Translation of Neuroprotection Therapies
Many neuroprotective and other therapies for treatment of acute ischemic stroke have failed in translation to human studies, indicating a need for more rigorous, multidimensional quality assessment of the totality of preclinical evidence supporting a therapy prior to conducting human trials. A conse...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918446/ https://www.ncbi.nlm.nih.gov/pubmed/34196953 http://dx.doi.org/10.1007/s12975-021-00922-4 |